Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Long-Term Investments (2014 - 2019)

Updated

Travere Therapeutics (TVTX) posted Long-Term Investments of $15 million for Q2 2019, unchanged from $15 million a year earlier and unchanged from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Long-Term Investments (2014 - 2019) Analysis & Trends

Since Q3 2014, Travere Therapeutics has reported Long-Term Investments for 7 quarters.

  • According to Business Quant data, Long-Term Investments for the three prior quarters was $15 million (Q1 2019), $15 million (Q4 2018) and $15 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 266.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.56 Bn
10 Travere Therapeutics 5.36 Bn 4.96 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 15.00 Mn
Mar 31, 2019 15.00 Mn
Dec 31, 2018 15.00 Mn
Sep 30, 2018 15.00 Mn
Jun 30, 2018 15.00 Mn
Mar 31, 2018 15.00 Mn
Sep 30, 2014 400,000.00
API Access

Travere Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=TVTX&period=max&api_key=YOUR_API_KEY